Modulation of early inflammatory response by different balanced and non-balanced colloids and crystalloids in a rodent model of endotoxemia

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Voigtsberger, Stefanie ^a   Urner, Martin ^a,b   Hasler, Melanie ^a   Z'Graggen, Birgit Roth ^b   Booy, Christa ^b   Spahn, Donat R ^a   Beck Schimmer, Beatrice ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; GELATIN; HETASTARCH; INTERCELLULAR ADHESION MOLECULE 1; LACTIC ACID; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, RAT; COLLOID; CRYSTALLOID; CXCL1 CHEMOKINE; CXCL1 PROTEIN, RAT; ISOTONIC SOLUTION;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BLOOD OXYGEN TENSION; CHEMICAL COMPOSITION; COLLOID; CONTROLLED STUDY; CRYSTALLOID; ENDOTOXEMIA; GENE EXPRESSION; HEMODYNAMICS; INFLAMMATION; KIDNEY; KIDNEY INJURY; KIDNEY PARENCHYMA; LIVER; LUNG; LUNG PARENCHYMA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; PHARMACOLOGY; THERAPEUTIC USE; WISTAR RAT;

ANIMALS; CHEMOKINE CCL2; CHEMOKINE CXCL1; COLLOIDS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; ISOTONIC SOLUTIONS; KIDNEY; LIVER; LUNG; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899453371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093863     Document Type: Article

References (42)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, et al. (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813-818. (Pubitemid 41175724)
2. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P (1996) Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 11: 293-299. (Pubitemid 26063074)
3. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, et al. (2008) Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 36: S198-203. (Pubitemid 351483052)
4. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, et al. (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34: 17-60.
5. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377.
6. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, et al. (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41: 580-637.
7. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, et al. (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357: 911-916. (Pubitemid 32247279)
8. Godet G (2001) Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet 358: 581; author reply 582.
9. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, et al. (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358: 125-139.
10. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, et al. (2012) Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 16: R94.
11. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, et al. (2012) Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis. N Engl J Med.
12. Soni N (2012) Hydroxyethylstarch 200/0.5 - the horse has bolted. Crit Care 16: 110.
13. Wittlinger M, Schlapfer M, De Conno E, Z'Graggen B R, Reyes L, et al. (2010) The effect of hydroxyethyl starches (HES 130/0.42 and HES 200/0.5) on activated renal tubular epithelial cells. Anesth Analg 110: 531-540.
14. Guidet B, Soni N, Della Rocca G, Kozek S, Vallet B, et al. (2010) A balanced view of balanced solutions. Crit Care 14: 325.
15. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
16. Schick MA, Isbary TJ, Schlegel N, Brugger J, Waschke J, et al. (2010) The impact of crystalloid and colloid infusion on the kidney in rodent sepsis. Intensive Care Med 36: 541-548.
17. Simon TP, Schuerholz T, Huter L, Sasse M, Heyder F, et al. (2012) Impairment of renal function using hyperoncotic colloids in a two hit model of shock: a prospective randomized study. Crit Care 16: R16.
18. Aksu U, Bezemer R, Demirci C, Ince C (2012) Acute effects of balanced versus unbalanced colloid resuscitation on renal macrocirculatory and microcirculatory perfusion during endotoxemic shock. Shock 37: 205-209.
19. Ertmer C, Kampmeier TG, Rehberg S, Morelli A, Kohler G, et al. (2011) Effects of balanced crystalloid vs. 0.9% saline-based vs. balanced 6% tetrastarch infusion on renal function and tubular integrity in ovine endotoxemic shock. Crit Care Med 39: 783-792.
20. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S (1987) Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1: 14-16.
21. Thaha M, Yogiantoro M, Soewanto Pranawa (2005) Correlation between intradialytic hypotension in patients undergoing routine hemodialysis and use of acetate compared in bicarbonate dialysate. Acta Med Indones 37: 145-148.
22. Davies PG, Venkatesh B, Morgan TJ, Presneill JJ, Kruger PS, et al. (2011) Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution. Crit Care 15: R21.
23. Veech RL, Gitomer WL (1988) The medical and metabolic consequences of administration of sodium acetate. Adv Enzyme Regul 27: 313-343.
24. Selby NM, Fluck RJ, Taal MW, McIntyre CW (2006) Effects of acetate-free double-chamber hemodiafiltration and standard dialysis on systemic hemodynamics and troponin T levels. ASAIO J 52: 62-69. (Pubitemid 44314899)
25. Feldkamp T, Kribben A, Roeser NF, Senter RA, Kemner S, et al. (2004) Preservation of complex I function during hypoxia-reoxygenation-induced mitochondrial injury in proximal tubules. Am J Physiol Renal Physiol 286: F749-759. (Pubitemid 38365094)
26. Bienholz A, Petrat F, Wenzel P, Ickerott P, Weinberg JM, et al. (2012) Adverse effects of alpha-ketoglutarate/malate in a rat model of acute kidney injury. Am J Physiol Renal Physiol 303: F56-63.
27. Handa O, Naito Y, Yoshikawa T (2006) Rat cytokine-induced neutrophil chemoattractant-1 (CINC-1) in inflammation. Journal of Clinical Biochemistry and Nutrition 38: 51-58.
28. Watanabe K, Suematsu M, Iida M, Takaishi K, Iizuka Y, et al. (1992) Effect of rat CINC/gro, a member of the interleukin-8 family, on leukocytes in microcirculation of the rat mesentery. Exp Mol Pathol 56: 60-69.
29. Ernandez T, Mayadas TN (2009) Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int 76: 262-276.
30. Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221.
31. Rabelink TJ, de Boer HC, van Zonneveld AJ (2010) Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol 6: 404-414.
32. Campbell SJ, Hughes PM, Iredale JP, Wilcockson DC, Waters S, et al. (2003) CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J 17: 1168-1170.
33. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Schildberg FW, et al. (2002) Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 97: 460-470. (Pubitemid 34847761)
34. Flower DR, North AC, Sansom CE (2000) The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta 1482: 9-24.
35. Urbschat A, Obermuller N, Haferkamp A (2011) Biomarkers of kidney injury. Biomarkers 16 Suppl 1: S22-30.
36. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, et al. (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543. (Pubitemid 37169339)
37. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54: 1012-1024.
38. Han M, Li Y, Liu M, Cong B (2012) Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat. BMC Nephrol 13: 25.
39. Goldstein SL (2011) Acute kidney injury biomarkers: renal angina and the need for a renal troponin I. BMC Med 9: 135.
40. Dejager L, Pinheiro I, Dejonckheere E, Libert C (2011) Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol 19: 198-208.
41. Taveira da Silva AM, Kaulbach HC, Chuidian FS, Lambert DR, Suffredini AF, et al. (1993) Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med 328: 1457-1460.
42. Doi K, Leelahavanichkul A, Yuen PS, Star RA (2009) Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119: 2868-2878.